clinical studylínchuáng yánjiū临床研究shows / indicatesxiǎnshì显示new drugxīn yào新药zorevunersen (epilepsy drug)Zuǒléifúnàsēn佐雷伏纳森to cause / makeshǐ使Dravet syndrome (severe epilepsy)Délāwéi Zōnghézhēng德拉韦综合征children with the diseasehuàn ér患儿epilepsy / seizuresdiānxián癫痫attacks / episodesfāzuò发作at mostzuì duō最多to reducejiǎnshǎo减少90 percentjiǔ chéng九成。
March 4, 2026 at 10:00 PM
New Words
News in English
Lifestyle & CultureClinical Trial Shows New Drug Zorevunersen Cuts Seizures by Up to 91 Percent in Children With Dravet Syndrome
Published in the New England Journal of Medicine, the study confirmed zorevunersen can reduce monthly seizure frequency in children with Dravet syndrome by up to 91 percent. The research team found the drug also improved cognitive function and quality of life over a three-year period, and has already launched a larger Phase 3 trial.
A clinical study published in the New England Journal of Medicine demonstrates that the novel drug zorevunersen can reduce epilepsy attacks in children with Dravet syndrome by as much as approximately 90 percent.
Dravet syndrome is a rare and severe hereditary epilepsy triggered by mutations in the SCN1A gene. Currently, there are no clinical treatments available to cure it completely.
This study enrolled a total of 81 children aged between 2 and 18 years with the disease. Participants experienced approximately 17 seizure episodes per month on average before receiving treatment.
The drug's mechanism of action involves increasing the production of protein from healthy copies of the SCN1A gene, thereby restoring nerve cell function.
The study also found that over a three-year trial period, the drug helped children with the disease improve their cognitive function and quality of life, with the majority experiencing relatively mild adverse reactions.
The positive preliminary results prompted the research team to launch a larger-scale phase 3 clinical trial, with patient enrollment expected to complete in the second quarter of 2026.
Analysts believe that if phase 3 data receives verification, zorevunersen may become the first disease-modifying therapy for Dravet syndrome patients, achieving milestone significance.
More in Lifestyle & Culture
the Arctic / ArcticBěijí北极permafrostyǒngjiǔ dòng tǔ永久冻土to accelerate / to speed upjiāsù加速to melt / to thawrónghuà融化，ancient / age-oldgǔlǎo古老organic carbonyǒujī tàn有机碳to flow intoliúrù流入ocean / seahǎiyáng海洋to raise / to triggeryǐnfā引发climateqìhòu气候warning / alertjǐngshì警示。
Thawing Arctic Permafrost Releases Ancient Carbon Into Oceans, Raising Climate Fears
newxīnxíng新型wearablekěchuāndài可穿戴patchtiēpiàn贴片acceleratejiāokuài加快peoplerénmen人们enterjìnrù进入deepshēndù深度sleepshuìmián睡眠。
New Wearable Patch Accelerates Entry Into REM Sleep by 43 Minutes
total solar eclipserìquánshí日全食todayjīnrì今日to cross / to pass throughchuānyuè穿越IcelandBīngdǎo冰岛andyǔ与SpainXībānyá西班牙。
Total Solar Eclipse Crosses Iceland and Spain Today
ChinaZhōng guó中国to be unearthed / to excavatechū tǔ出土the Warring States periodZhàn guó战国bronzeqīng tóng青铜wine vesseljiǔ qì酒器，containing insidenèi cáng内藏dating back from nowjù jīn距今approximatelyyuē约2,300 years2300 nián2300年(modifier particle)de的ancientgǔ dài古代fine wineměi jiǔ美酒。
Warring States Bronze Vessel Containing 2,300-Year-Old Wine Unearthed in China